Pediatrix Medical Group MD Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $205.78M-45.2% | $375.24M+10.3% | $340.06M+51.3% | $224.73M+127% | $98.98M-57.0% | ||
| $123.19M-1.0% | $124.48M+1.2% | $123.04M-0.4% | $123.59M+2.8% | $120.2M+1.4% | ||
| $224.8M-2.1% | $229.67M-0.6% | $231.12M-3.3% | $238.99M-1.5% | $242.53M-6.7% | ||
| $587.03M-23.1% | $763.51M+6.5% | $717.2M+17.0% | $613.05M+24.7% | $491.67M-23.1% | ||
| $41.09M+4.9% | $39.18M+1.4% | $38.64M-0.8% | $38.94M+1.9% | $38.22M-2.4% | ||
| $1.27B+0.6% | $1.26B+0.4% | $1.26B+1.0% | $1.24B0.0% | $1.24B0.0% | ||
| $15.94M-5.5% | $16.86M+13.9% | $14.8M+59.2% | $9.3M-10.5% | $10.39M-10.4% | ||
| $2.07B-7.9% | $2.25B+2.2% | $2.2B+4.6% | $2.1B+5.4% | $1.99B-7.4% | ||
| $31.54M-15.3% | $37.22M-3.7% | $38.65M-8.1% | $42.07M-4.7% | $44.12M-5.0% | ||
| $192.42M+618% | $26.81M+5.8% | $25.34M+7.0% | $23.69M+7.0% | $22.13M+7.7% | ||
| $442.64M-3.5% | $458.91M+16.9% | $392.55M+15.1% | $341.04M+25.8% | $271.05M-37.6% | ||
| $398.35M-30.2% | $570.53M-1.1% | $577.17M— | —— | —— | ||
| $1.19B-13.7% | $1.38B+5.5% | $1.31B+3.2% | $1.27B+5.3% | $1.2B-13.2% | ||
| 200M0.0% | 200M-99.9% | 200B0.0% | 200B0.0% | 200B+23,282,787% | ||
| -$53.58M+35.6% | -$83.15M+28.8% | -$116.84M+38.0% | -$188.54M+17.2% | -$227.8M+8.3% | ||
| $878.58M+1.5% | $865.85M-2.8% | $890.67M+6.8% | $833.75M+5.6% | $789.19M+3.2% | ||
| $2.07B-7.9% | $2.25B+2.2% | $2.2B+4.6% | $2.1B+5.4% | $1.99B-7.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Pediatrix Medical Group cover its short-term obligations?
- Its current ratio is 1.33 — current assets exceed current liabilities.
- Where does Pediatrix Medical Group's balance sheet data come from?
- Every line is extracted from Pediatrix Medical Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.